BSECompany Update27 Aug 2026 · 27 Aug 2026, 05:17 pm

Please find the enclosed copy of the letter dispatched by the company to the shareholders (whose email id not registered) for providing details to access the Annual Report for FY 2025-26.

Bharat Parenterals Ltd · 541096

✦ AI Summary

Bharat Parenterals Ltd has dispatched a letter to shareholders whose email addresses are not registered with the company, providing a web-link to access the Annual Report for FY 2025-26 and the Notice convening the 33rd Annual General Meeting (AGM).

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bharat Parenterals Ltd - 541096 - Intimation Under Regulation 36 Of The SEBI (LODR) Regulations, 2015.

Attachments (1)

📄

24a2f38d-e4a8-445f-b913-64f9ae47b70a.pdf

pdf

Download →
View document text
Date: August 27, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai –400 001 Scrip Code: 541096 Sub: Dispatch of letter to shareholders whose e-mail addresses are not registered with Company/Registrar & Transfer Agent/Depository Participants. Ref: Regulation 30 and 36(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, This is to inform you that, in accordance with Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has dispatched a letter to those Members whose e-mail addresses are not registered with the Company, its Registrar & Transfer Agent, or the Depositories. The letter provides a web-link to access the Annual Report for the Financial Year 2025-26 and the Notice convening the 33rd Annual General Meeting (AGM) of the Company. The above information is also available on the website of the Company at www.bplindia.in. The above is for your information and record. Yours Sincerely, For, Bharat Parenterals Limited Sharmin Soni Company Secretary & Compliance Officer ICSI Membership No: ACS-75694 Encl: AS Above BHARAT PARENTERALS LIMITED CIN: L24231GJ1992PLC018237 Reg. Off: Survey No. 144-A, Jarod-Samlaya Road, Vill. Haripura, Tal. Savli, Vadodara-391520, Gujarat. Email: cs@bplindia.in Website: www.bplindia.in Telephone: +91-02667-251679/9909928332 Date: August 27, 2026 Dear Shareholder, Sub.: Notice of 33rd Annual General Meeting and Annual Report of Bharat Parenterals Limited (BPLPHARMA). Dear Members, We are pleased to inform you that the 33rd Annual General Meeting ("AGM") of the Members of the Company is scheduled to be held on Saturday, the September 19, 2026 at 11:00 A.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) and the venue of the meeting shall be deemed to be the Registered Office of the company at ‘Survey No.144A, Jarod Samlaya Road, Haripura, Savli, Vadodara, Gujarat, 391520 to transact the business as set out in the Notice of the 33rdAnnual General Meeting. In compliance with Regulation 36(1)(b) of the SEBI Listing Regulations, we would like to inform you that the Annual Report of the Company for the Financial Year 2025-26 are available on the Company's website at – www.bplindia.in Members may access the Annual Report by visiting the Company's website at www.bplindia.in and navigation to: Home InvestorsAnnual Report2025-26 We would further like to inform that Saturday, September 12, 2026 is the cut-off date for ascertaining the names of the Members holding shares who will be entitled to cast their votes electronically in respect of the businesses to be transacted at the AGM. The Company encourages its Members to register or update their email IDs with the Depository Participants/Registrar to receive all communications electronically. Members holding shares in physical form are requested to consider dematerializing their holdings to ensure compliance with SEBI guidelines and to facilitate faster and safer transactions. The formats for choice of Nomination and Updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 are available on our website at https://www.bplindia.in/investor- shareholder-services-requests.html In case of any queries, Members may send an email to the Company’s Registrar and Transfer Agent, Adroit Corporate Services Private Limited (‘RTA’) at info@adroitcorporate.com We sincerely appreciate your continued support and look forward to your cooperation in embracing our journey towards greater digitization and seamless communication Thanking you, Yours faithfully, For Bharat Parenterals Limited Sd/- Mr. Sharmin Soni Company Secretary & Compliance Officer (ICSI M. No: - A75694)